What are the ADHD treatment options for individuals with qualitative or functional platelet defects?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18430068
Cited by: 0

Abstract

Atomoxetine may be an appropriate ADHD treatment for those with qualitative or functional platelet defects where methylphenidate-induced thrombocytopenia poses a risk.

Fields of Study & Subjects

Attention Deficit Hyperactivity Disorder Platelet Disorders and Treatments Antiplatelet Therapy and Cardiovascular Diseases

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
30 January 2026